These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6606214)

  • 1. Circulating immune complexes in haemophilia and von Willebrand's disease.
    Passaleva A; Massai G; Morfini M; Longo G; Rossi Ferrini PL; Ricci M
    Scand J Haematol; 1983 Nov; 31(5):466-74. PubMed ID: 6606214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of circulating immune complexes on transfusional therapy in patients with hemophilia or von Willebrand's disease.
    Celada A; Aguado MT; Maire M; Ortega F; Magallon M; Martin-Villar J; Lambert PH
    Transfusion; 1984; 24(1):46-52. PubMed ID: 6420954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in hemophilia.
    Poskitt TR; Poskitt PK; Bean CA; Arkel YS
    Am J Hematol; 1981 Sep; 11(2):147-52. PubMed ID: 6795922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with bleeding disorders.
    Anh-Tuan N; Novák E; Hollán SR
    Vox Sang; 1981 Jan; 40(1):12-6. PubMed ID: 6971526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver dysfunction in patients with hemophilia A, B, and von Willebrand's disease.
    Hilgartner MW; Giardina P
    Transfusion; 1977; 17(5):495-9. PubMed ID: 302996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and clinical and transfusional significance of rheumatoid factor in patients with haemophilia and von Willebrand's disease.
    Celada A; Aguado MT; Ortega F; Magallon M; Martin-Villar J; Lambert PH
    Vox Sang; 1984; 47(4):271-5. PubMed ID: 6333107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
    Mannucci PM; Mari D
    Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor VIII:C and VIII:CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma.
    Holmberg L; Borge L; Nilsson IM
    Br J Haematol; 1981 Apr; 47(4):587-96. PubMed ID: 6783063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A.
    Holmberg L; Mannucci PM; Turesson I; Ruggeri ZM; Nilsson IM
    Scand J Haematol; 1974; 13(1):33-8. PubMed ID: 4606548
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy in viral inactivation of the concentrates of factor VIII and IX by the solvent/detergent procedure. Evaluation in patients with hemophilia].
    Guerois C; Parquet A; Vicariot M; Lecoeur FF; Maisonneuve P; Courouce AM; Dubois F; Laurian Y
    Presse Med; 1991 Jun; 20(25):1163-6. PubMed ID: 1830653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver dysfunction in haemophilia A, B and other hereditary haemorrhagic disorders.
    Ng HW
    Ann Acad Med Singap; 1984 Jul; 13(3):524-6. PubMed ID: 6335008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia in Sweden. Studies on demography of hemophilia and surgery in hemophilia and von Willebrand's disease.
    Larsson SA
    Acta Med Scand Suppl; 1984; 684():1-72. PubMed ID: 6611018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A.
    Kazatchkine MD; Sultan Y; Burton-Kee EJ; Mowbray JF
    Clin Exp Immunol; 1980 Feb; 39(2):315-20. PubMed ID: 6771074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of cell mediated and humoral immunity in haemophilia and related disorders.
    Moffat EH; Bloom AL; Jones J; Matthews N; Newcombe RG
    Br J Haematol; 1985 Sep; 61(1):157-67. PubMed ID: 3931666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.
    Schulman S; Wiechel B
    Acta Med Scand; 1984; 215(3):249-56. PubMed ID: 6610281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunoradiometric assay for procoagulant factor VIII antigen: results in haemophilia, von Willebrand's disease and fetal plasma and serum.
    Peake IR; Bloom AL; Giddings JC; Ludlam CA
    Br J Haematol; 1979 Jun; 42(2):269-81. PubMed ID: 313808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic diseases.
    Enck RE; Betts RF; Brown MR; Miller G
    Transfusion; 1979; 19(1):32-8. PubMed ID: 219564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.